207 related articles for article (PubMed ID: 25747806)
1. Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib.
Wu KL; Tsai MJ; Yang CJ; Chang WA; Hung JY; Yen CJ; Shen CH; Kuo TY; Lee JY; Chou SH; Liu TC; Chong IW; Huang MS
Lung Cancer; 2015 May; 88(2):187-94. PubMed ID: 25747806
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR-mutated advanced non-small-cell lung.
Kuo CY; Tsai MJ; Hung JY; Lee MH; Wu KL; Tsai YC; Chuang CH; Huang CW; Chen CL; Yang CJ; Chong IW
Kaohsiung J Med Sci; 2024 May; 40(5):467-476. PubMed ID: 38523603
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma.
Toyooka S; Takano T; Kosaka T; Hotta K; Matsuo K; Ichihara S; Fujiwara Y; Soh J; Otani H; Kiura K; Aoe K; Yatabe Y; Ohe Y; Mitsudomi T; Date H
Cancer Sci; 2008 Feb; 99(2):303-8. PubMed ID: 18271929
[TBL] [Abstract][Full Text] [Related]
4. MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation.
Noro R; Seike M; Zou F; Soeno C; Matsuda K; Sugano T; Nishijima N; Matsumoto M; Kitamura K; Kosaihira S; Minegishi Y; Yoshimura A; Kubota K; Gemma A
BMC Cancer; 2015 Feb; 15():31. PubMed ID: 25886066
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of combining EGFR-TKIs and radiotherapy in Stage IV lung adenocarcinoma with 19-Del or 21-L858R mutations: A real-world study.
Liang S; Wang H; Zhang Y; Tian H; Li C; Hua D
Cancer Med; 2024 Apr; 13(8):e7208. PubMed ID: 38659399
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II study of gefitinib (Iressa(®)) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer.
Han JY; Lee SH; Lee GK; Yun T; Lee YJ; Hwang KH; Kim JY; Kim HT
Cancer Chemother Pharmacol; 2015 Mar; 75(3):475-83. PubMed ID: 25552401
[TBL] [Abstract][Full Text] [Related]
7. GM3 synthase gene is a novel biomarker for histological classification and drug sensitivity against epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
Noguchi M; Suzuki T; Kabayama K; Takahashi H; Chiba H; Shiratori M; Abe S; Watanabe A; Satoh M; Hasegawa T; Tagami S; Ishii A; Saitoh M; Kaneko M; Iseki K; Igarashi Y; Inokuchi J
Cancer Sci; 2007 Oct; 98(10):1625-32. PubMed ID: 17711504
[TBL] [Abstract][Full Text] [Related]
8. [Classification and regression tree analysis of clinical patterns to predict the survival of patients with advanced non-small cell lung cancer treated with erlotinib].
Liu Y; Guo J; Wang Y; Yang J; Wang Z
Zhongguo Fei Ai Za Zhi; 2011 Oct; 14(10):785-9. PubMed ID: 22008108
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.
Traynor AM; Schiller JH; Stabile LP; Kolesar JM; Eickhoff JC; Dacic S; Hoang T; Dubey S; Marcotte SM; Siegfried JM
Lung Cancer; 2009 Apr; 64(1):51-9. PubMed ID: 18701186
[TBL] [Abstract][Full Text] [Related]
10. Case report: Target and immunotherapy of a lung adenocarcinoma with enteric differentiation,
Yang M; Yu P; He Z; Deng J
Front Immunol; 2023; 14():1266304. PubMed ID: 38332908
[TBL] [Abstract][Full Text] [Related]
11. Influence of histological type, smoking history and chemotherapy on survival after first-line therapy in patients with advanced non-small cell lung cancer.
Itaya T; Yamaoto N; Ando M; Ebisawa M; Nakamura Y; Murakami H; Asai G; Endo M; Takahashi T
Cancer Sci; 2007 Feb; 98(2):226-30. PubMed ID: 17233840
[TBL] [Abstract][Full Text] [Related]
12. [Selection of postoperative adjuvant therapy for patients with stage IB lung adenocarcinoma: analysis of 653 cases].
Shen L; Chen Y; Yun T; Guo J; Liu X; Zhang T; Liang C; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):989-997. PubMed ID: 38862458
[TBL] [Abstract][Full Text] [Related]
13. [Aprospective study of detection and clinical significance of bone marrow tumor cells in small cell lung cancer].
Wang Y; Lu BH; Gao Y; Liu YX; Hu MM; Che NY; Lin HF; Li HX; Zhang HM; Zhang TM
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):419-427. PubMed ID: 38742355
[No Abstract] [Full Text] [Related]
14. Surgical Outcomes in Non-Small Cell Lung Cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
Park S; Choe J; Lee SM; Choi S; Kim MJ; Chae EJ; Seo JB
Ann Surg Oncol; 2024 May; 31(5):3448-3458. PubMed ID: 38386197
[TBL] [Abstract][Full Text] [Related]
15. [Survival analysis of 1,742 patients with stage IV non-small cell lung cancer].
Peng H; Ma M; Han B
Zhongguo Fei Ai Za Zhi; 2011 Apr; 14(4):362-6. PubMed ID: 21496437
[TBL] [Abstract][Full Text] [Related]
16. Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort.
Li Y; Wong M; Zhan L; Corke L; Brown MC; Cheng S; Khan K; Balatnaram K; Chowdhury M; Sabouhanian A; Herman J; Walia P; Strom E; Patel D; García-Pardo M; Schmid S; Eng L; Sacher AG; Leighl N; Bradbury PA; Shepherd FA; Shultz D; Liu G
Lung Cancer; 2024 Jun; 192():107823. PubMed ID: 38763103
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Baseline Vitamin D Level in Patients Receiving Gefitinib-Directed Therapy for EGFR-Mutant Non-Small-Cell Lung Cancer.
Noronha V; Kolkur M; ArunKumar R; Adak S; Patil V; Menon N; Shah M; Prabhash K
Clin Med Insights Oncol; 2024; 18():11795549241254460. PubMed ID: 38827521
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of SIRI in patients with late-stage lung adenocarcinoma receiving EGFR-TKI treatment.
Wang H; Li W
Curr Probl Cancer; 2024 May; 50():101099. PubMed ID: 38723294
[TBL] [Abstract][Full Text] [Related]
19. Impact of smoking in resected lung cancer depends on epidermal growth factor receptor mutation.
Sekihara K; Kawase A; Matsubayashi Y; Tajiri T; Shibata M; Hayakawa T; Shiiya N; Funai K
Interdiscip Cardiovasc Thorac Surg; 2024 Jun; ():. PubMed ID: 38851874
[TBL] [Abstract][Full Text] [Related]
20. Metastatic pattern and prognosis in patients with lung adenosquamous carcinoma: A surveillance, epidemiology, and end results-based population study.
Xie J; Li C
Heliyon; 2024 May; 10(9):e30641. PubMed ID: 38765098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
